TABLE 2

Gene expressed differently in isochaihulactone-treated A549 cells

Human lung adenocarcinoma A549 cells were treated with vehicle (0.2% DMSO) or isochaihulactone for 48 h and gene expression was determined using microarray analysis.


Functional Classification and Accession No.

Representative Gene Name

Changeb
-fold
Signal transduction
    NG_005645 GABA receptor-associated protein-like 3 2.29
    NM_002222 Inositol 1,4,5-triphosphate receptor, type 1 3.21
    BC 013992 Mitogen-activated protein kinase 3 (MAPK3) 2.05
    BC 031574 Mitogen-activated protein kinase 14 (MAPK14) 2.01
    NM 004864 NSAID-activated gene 1 (NAG-1) 12.5
    NM 031412 GABAA receptor-associated protein-like 1 2.33
    NM 016215 EGF-like-domain, multiple 7 2.09
Transcript factor
    NM 003131 Serum response factor (c-fos) 4.10
    NM 001964 Early growth response-1 (EGR-1) 6.10
    BC 128420 Heat shock transcription factor 2 2.68
Cytoskeleton
    NM 053027 Myosin, light polypeptide 2.17
    NM 000366 Tropomyosin 1 (α) 2.13
    NM 004924 Actinin, α4 2.32
Cell cycle
    BT 006630 CDC28 protein kinase 2 2.27
    NM 003478 Cullin 5 3.89
    BC 000312 P21/WAF1 3.82
    NM 001799 Cyclin-dependent kinase 7 2.18
Apoptosis
    NM 007106 Ubiquitin-like 3 3.58
    BC 008320 Endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 2.43
    NM 032992 Caspase 6 2.01
    NP_061178 FEM-1 1.89
Growth factor
    NM_013956 Neuregulin-1 (NRG-1) 4.37
    NM_002006
Fibroblast growth factor-2 (FGF-2)
1.74
  • a Genes listed were increased by ≥ 1.5-fold a measured by Affymetrix GeneChip Software comparisons of isochaihulactone-treated versus vehicle-treated A549 cells.